Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCT-I10A in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
CTR20191159Phase 2Completed
- Sponsor
- Sinocelltech Group Limited
- Start
- Aug 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of finotonlimab in head and neck squamous cell carcinoma (HNSCC), sponsored by Sinocelltech Group Limited. Started Aug 2019; status: completed.
02
Drugs
finotonlimab
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on CTR20191159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191159.